SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Clinical trials for SYSTEM LUPUS ERYTHEMATOSUS(SLE) explained in plain language.

Never miss a new study

Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear

Sign up with your email to follow new studies for SYSTEM LUPUS ERYTHEMATOSUS(SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Experimental cell therapy targets devastating autoimmune diseases that resist standard treatments

Disease control Recruiting now

This is an early-stage study testing a new cell therapy called EVM18001 for people with severe, hard-to-treat autoimmune diseases: lupus, scleroderma, and myasthenia gravis. The main goal is to check if the treatment is safe and to find the right dose. Researchers will also look …

Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SYSTEM LUPUS ERYTHEMATOSUS(SLE)

Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear

Experimental cell therapy targets devastating autoimmune diseases that resist standard treatments